Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 3/20 | 0.41 |
| ▸ | HTR2B | P41595 | 3/20 | 0.41 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.39 |
| ▸ | ANPEP | P15144 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CDK4 | P11802 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CCND1 | P24385 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6652555 | 0.79 | AADAT (0.46) | PLAUHTR2CHTR2BMEN1KMT2A | |
| SCHEMBL23346885 | 0.78 | PLAU (0.42) | PLAUHTR2CHTR2BSRD5A1ANPEP | |
| SCHEMBL9685608 | 0.78 | TSHR (0.41) | PLAUHTR2CHTR2BSRD5A1ANPEP | |
| SCHEMBL9396982 | 0.78 | GAA (0.50) | HTR2CHTR2BSRD5A1TSHRMEN1 | |
| SCHEMBL8554748 | 0.76 | TSHR (0.42) | PLAUHTR2CHTR2BSRD5A1TSHR | |
| SCHEMBL8554573 | 0.72 | MTNR1A (0.41) | TSHRGAASMN1; SMN2CHRM2CHRM1 | |
| SCHEMBL28510390 | 0.71 | ANPEP (0.50) | SRD5A1ANPEP | |
| SCHEMBL7387071 | 0.70 | ALDH1A1 (0.45) | TSHRALDH1A1GAA | |
| SCHEMBL21965899 | 0.70 | MTNR1A (0.49) | MEN1ALDH1A1KMT2AHTR2ACHRM2 | |
| SCHEMBL7387073 | 0.70 | ALDH1A1 (0.53) | TSHRMEN1ALDH1A1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1413286-B1 | Dyeing composition comprising at least one heterocyclic oxidation base and at least one substituted 2,3-diaminopyridine as a coupling agent | OREAL (FR) | 2009-04-22 | — | — | EP | claimed |
| WO-2007071688-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, A PARTICULAR OXIDATION BASE AND A COUPLER | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | claimed |
| EP-2175830-B1 | COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES | ORÉAL L (FR) | 2015-09-30 | — | — | EP | disclosed |
| US-8557838-B2 | Immune response modifier formulations containing oleic acid and methods | MEDICIS PHARMACEUTICAL CORPORATION (US) | 2013-10-15 | — | — | US | disclosed |
| CN-101939313-B | 3,8-diaminotetrahydroquinoline derivative | ZERIA PHARM CO LTD | 2013-05-22 | — | — | CN | disclosed |
| US-20120237551-A1 | IMMUNE RESPONSE MODIFIER FORMULATIONS CONTAINING OLEIC ACID AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-09-20 | — | — | US | disclosed |
| US-8043385-B2 | Composition oxidation colouring of keratinic fibres, containing a cationic cellulose ether, a metasilicate and oxidation dyes, method for oxidation colouring and uses thereof | L'OREAL S.A. (FR) | 2011-10-25 | — | — | US | disclosed |
| US-8002847-B2 | Composition for oxidation dyeing keratin fibres comprising a cationic cellulose ether, a weakly oxyethylenated sorbitan fatty acid ester and oxidation dyes | L 'OREAL S.A. (FR) | 2011-08-23 | — | — | US | disclosed |
| US-7939555-B2 | Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-05-10 | — | — | US | disclosed |
| US-7928116-B2 | Method of treating actinic keratosis | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-04-19 | — | — | US | disclosed |
| US-7928118-B2 | Reduction of imiquimod impurities in pharmaceutical creams | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-04-19 | — | — | US | disclosed |
| US-20100120831-A1 | METHODS FOR IMPROVING IMIQUIMOD AVAILABILITY AT TWO MONTHS, FOUR MONTHS AND SIX MONTHS BETWEEN REFINED AND COMPENDIAL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100120832-A1 | METHOD OF PREPARING A PHARMACEUTICAL CREAM AND MINIMIZING IMIQUIMOD IMPURITY FORMATION (AT LEAST FOUR MONTHS STORAGE) | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100120829-A1 | X-FOLD LESS IMIQUIMOD IMPURITIES AT SIX MONTHS BETWEEN REFINED AND COMPENDIAL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-05-13 | — | — | US | disclosed |
| EP-2175830-A2 | COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES | L'Oreal (FR) | 2010-04-21 | — | — | EP | disclosed |
| US-7655672-B2 | Immune response modifier formulations containing oleic acid and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-02-02 | — | — | US | disclosed |
| US-20090093514-A1 | IMMUNE RESPONSE MODIFIER FORMULATIONS CONTAINING OLEIC ACID AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2009-04-09 | — | — | US | disclosed |
| WO-2009016061-A2 | COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES | L'OREAL (FR) | 2009-02-05 | — | — | WO | disclosed |
| WO-2007071688-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, A PARTICULAR OXIDATION BASE AND A COUPLER | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | disclosed |
| US-20070123558-A1 | IMMUNE RESPONSE MODIFIER FORMULATIONS CONTAINING OLEIC ACID AND METHODS | BAUSCH & LOMB INCORPORATED | 2007-05-31 | — | — | US | disclosed |